NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Raphael Pharmaceutical Inc. (“Raphael Pharmaceutical” or the “Company”) (OTCQB: RAPH), a clinical-stage biotechnology company developing an innovative ...
Continued expansion of IP portfolio related to RNA delivery Treatment of rheumatoid arthritis as one of the key therapeutic indications The provisional patent application describes novel nanoparticle ...
TUCSON, Ariz., March 2, 2026 /PRNewswire/ -- Keys Inc. today announced the filing of U.S. Provisional Patent Application No. 63/939,152 with the United States Patent and Trademark Office (USPTO) ...
LegalZoom’s law firm to provide affordable patent protection through intelligent technology and licensed patent attorneys at a fraction of traditional costs MOUNTAIN VIEW, Calif.--(BUSINESS ...
NAPLES, Fla. and CAMBRIDGE, United Kingdom, March 05, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”) today notes the announcement issued by Sarborg Limited (“Sarborg”) ...
Provisional patent applications are patent applications filed with the United States Patent and Trademark Office (USPTO). but not examined by it. They are placeholders, establishing a patent filing ...
NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Raphael Pharmaceutical Inc. (RAPH), a clinical-stage biotechnology company developing an innovative research platform based on cannabinoids free of THC and ...
Continued expansion of IP portfolio related to RNA delivery Treatment of rheumatoid arthritis as one of the key therapeutic indications HAMILTON, BERMUDA / May 1, 2024 / Altamira Therapeutics Ltd.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results